Navigation Links
Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
Date:4/17/2008

Ended Ended

Adjusted Net income December 31, 2007 December 31, 2006

($ in thousands except

per share data) Diluted Diluted

Net Income (Loss) Diluted EPS Net Income EPS Net Income EPS

Adjusted Amount 3,431,557 0.08 2,042,291 0.05

Adjustments

Non cash debt financing

costs(1) (475,390) (0.01) --

Allowance for sales returns(2) -- -- (2,200,000) (0.05)

Forgiveness of income and

value-value added taxes(3) 2,160,795 0.05 --

Amount per consolidated

statement of operations 5,116,962 0.12 (157,709) 0.00

(1) Non cash debt financing costs for 2007 includes amortization of debt

issue costs of $58,680 and amortization of debt discount of $416,710

(2) Allowance for sales returns related to products sold in the fourth

quarter of 2006 and recognized in the second and third quarter of

2007

(3) Tax waiver from the Chinese local government

For the Year ended For the Year ended

Adjusted Net income December 31, 2007 December 31, 2006

($ in thousands except

per share data) Diluted Diluted

Net Income (Loss) Diluted EPS Net Income EPS Net Income EPS

Adjusted Amount 8,520,196 0.19 6,343,020 0.16

Adjustments

Non cash debt financing

costs(1) (1,663,863) (0.04) -- --

Allowance for sales returns(2) 2,200,000 0.05 (2,200,000) 0.06

Forgiveness of income and

value-value added taxes(3) 2,160,795 0.05 -- --

Amount per consolidated

statement of
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Lotus Blossom Consulting Announces E-Book on Infertility Treatment Financing
2. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
3. Lotus Pharmaceuticals Raises $5 Million in Private Placement
4. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
9. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
10. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
11. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... The distribution of white matter brain ... (MTBI) closely resembles that found in early Alzheimer’s dementia, ... journal Radiology. , “Findings of MTBI bear a ... said the study’s lead author, Saeed Fakhran, M.D., assistant ... the University of Pittsburgh School of Medicine. “Additional research ...
(Date:6/17/2013)... 18, 2013 Essential tremor (ET) is ... estimated 10 million people in the United States, and ... clear understanding what causes ET, there are no medications ... cure. Tulips for Tremor© is the International Essential Tremor ... of and a cure for this life-altering neurological condition. ...
(Date:6/17/2013)... BROOK, Ill. The distribution of white matter brain ... (MTBI) closely resembles that found in early Alzheimer,s dementia, ... journal Radiology . , "Findings of MTBI ... Alzheimer,s dementia," said the study,s lead author, Saeed Fakhran, ... Neuroradiology at the University of Pittsburgh School of Medicine. ...
(Date:6/17/2013)... Daimer Industries, Inc.®, a well-renowned U.S. based ... as expertly designed carpet steam cleaner and vapor steam ... for apartment dwellers and homeowners. The commercial steam cleaner ... and pressure levels up to 75 psi to clean ... to clean carpet spots and areas in homes, but ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Nearly 26 ... as many as 79 million adults are estimated to ... to prevent type 2 diabetes through weight loss and ... can help bring your blood sugar level back within ... and factors, 101 Medical Weight Loss physicians can help ...
Breaking Medicine News(10 mins):Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4
... heart surgery fare better if they receive reconstituted blood ... ,Investigators say that children who received reconstituted blood -- ... plasma -- tended to accumulate less fluid, which leads ... researchers compared results for 200 infants who underwent heart ...
... research shows consuming large quantities of alcohol may increase ... ,Researchers studied more than 47,000 men and women. Participants ... and what type of alcohol they consumed. It was ... grams of alcohol each day, while the women consumed ...
... treating benign tumors outside the brain using the CyberKnife ... progression with minimal toxicity. CyberKnife is a non-invasive robotic ... without open surgery. It uses a robotic arm, controlled ... radiation directly to the tumor site. ,During ...
... shows that a common class of drugs used for acute ... to treat.// ,Researchers studied the use of bronchodilators known ... relieve acute asthma attacks. The drugs come in many forms ... pill or liquid form, delivered in a nebulizer, or given ...
... when they are diagnosed with early-stage breast cancer are at ... normal weight.// ,Studies in the past have shown that ... has also shown to have contradictory results about the influence ... researchers say, they have demonstrated a significant association between obesity ...
... known to cause cognitive and behavioral changes in diabetics, ... blood sugar // has a similar effect. ... cognitive functioning and experience deterioration in mood when their ... blood sugar levels due to insulin deficiencies. Patients often ...
Cached Medicine News:
(Date:6/17/2013)...  Ochsner Health System today announced the contract ... medication safety by simplifying and standardizing the medication ... The CareFusion Pyxis ® ES platform ... helps hospitals significantly reduce time for nursing and ... simpler, more efficient workflows. The system also eliminates ...
(Date:6/17/2013)... June 17, 2013  AbbVie (NYSE: ... Phase I study of ABT-199/GDC-0199, an investigational BCL-2 ... high-risk relapsed/refractory chronic lymphocytic leukemia (CLL), and in ... patients are those with deletions of chromosome 17p ... These data were presented at the 18 th ...
(Date:6/17/2013)... , June 17, 2013 Johnson & ... a definitive agreement to acquire Aragon Pharmaceuticals, Inc., ... on drugs to treat hormonally-driven cancers. ... program.  Aragon,s lead product candidate is a second ... 2 development for castration resistant prostate cancer (CRPC). ...
Breaking Medicine Technology:Ochsner Health System Improves Safety Through Advanced Medication Management Technology 2Ochsner Health System Improves Safety Through Advanced Medication Management Technology 3Ochsner Health System Improves Safety Through Advanced Medication Management Technology 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 5AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 2AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 3AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 4AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 5AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 6Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 3
... Data Continue to Highlight Potential of NeoVista,s ... Epiretinal Brachytherapy, ... from the company,s Phase II feasibility study,examining its novel epiretinal brachytherapy ... the 41st Scientific Meeting of,the Retina Society. The long-term data from ...
... to improve healthcare,system in the Democratic Republic of ... The Clinton Global,Initiative recognized BD (Becton, Dickinson and ... technology company, for its commitment to the,Dikembe Mutombo ... worker safety at the Biamba Marie Mutombo Hospital ...
Cached Medicine Technology:NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 2NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 3NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 4Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: